Our manufacturing facility supports the production of API advanced intermediates, fine chemicals, and specialty chemicals with a focus on cGMP compliance, process efficiency, quality assurance, and seamless scale-up from pilot to commercial production.
Manufacturing Block-1 is a premier production unit engineered for the synthesis of specialty chemicals, pharmaceutical intermediates, and fine chemicals. With a total capacity of 71 KL, the facility supports high-efficiency, multi-product campaigns through a versatile infrastructure capable of operating across a temperature range of -70°C to 250°C
Our Block-II is designed to support process development, scale-up studies, technology transfer, and small-scale commercial manufacturing of specialty chemicals, intermediates, and fine chemicals. The facility is equipped with versatile reaction, separation, drying, and milling systems, enabling efficient handling of diverse chemical processes under controlled conditions.
The Pilot Block serves as a critical bridge between laboratory development and commercial production, ensuring smooth scale-up, consistent product quality, and accelerated process commercialization.
Manufacturing Block-III, which will feature a similar capacity to Block-I, is currently under construction. It is expected to be operational by the beginning of 2027.
Our state-of-the-art Quality Control (QC) Laboratory ensures that all API intermediates and specialty chemicals meet stringent global standards. Our facility is equipped with advanced analytical instrumentation to guarantee accuracy, reliability, and data integrity across the product lifecycle.
The Pilot Block serves as a critical bridge between laboratory development and commercial production, ensuring smooth scale-up, consistent product quality, and accelerated process commercialization.
Your Reliable Partner for API Intermediates
Connect with us online for updates, breakthroughs, & lab highlights.